These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

297 related items for PubMed ID: 22995118

  • 1. Edwards SAPIEN 3 valve.
    Binder RK, Rodés-Cabau J, Wood DA, Webb JG.
    EuroIntervention; 2012 Sep; 8 Suppl Q():Q83-7. PubMed ID: 22995118
    [Abstract] [Full Text] [Related]

  • 2. Transcatheter aortic valve replacement with the SAPIEN 3: a new balloon-expandable transcatheter heart valve.
    Binder RK, Rodés-Cabau J, Wood DA, Mok M, Leipsic J, De Larochellière R, Toggweiler S, Dumont E, Freeman M, Willson AB, Webb JG.
    JACC Cardiovasc Interv; 2013 Mar; 6(3):293-300. PubMed ID: 23517842
    [Abstract] [Full Text] [Related]

  • 3. A Strategy of Underexpansion and Ad Hoc Post-Dilation of Balloon-Expandable Transcatheter Aortic Valves in Patients at Risk of Annular Injury: Favorable Mid-Term Outcomes.
    Tan JS, Leipsic J, Perlman G, Stub D, Dvir D, Hansson NC, Norgaard BL, Blanke P, Cheung A, Ye J, Thompson CR, Moss RR, Lauck S, Wood D, Webb J.
    JACC Cardiovasc Interv; 2015 Nov; 8(13):1727-32. PubMed ID: 26476612
    [Abstract] [Full Text] [Related]

  • 4. Symetis ACURATE TA valve.
    Kempfert J, Möllmann H, Walther T.
    EuroIntervention; 2012 Sep; 8 Suppl Q():Q102-9. PubMed ID: 22995104
    [Abstract] [Full Text] [Related]

  • 5. Impact of post-implant SAPIEN XT geometry and position on conduction disturbances, hemodynamic performance, and paravalvular regurgitation.
    Binder RK, Webb JG, Toggweiler S, Freeman M, Barbanti M, Willson AB, Alhassan D, Hague CJ, Wood DA, Leipsic J.
    JACC Cardiovasc Interv; 2013 May; 6(5):462-8. PubMed ID: 23702010
    [Abstract] [Full Text] [Related]

  • 6. Use of balloon expandable transcatheter valves for valve-in-valve implantation in patients with degenerative stentless aortic bioprostheses: Technical considerations and results.
    Bapat V, Davies W, Attia R, Hancock J, Bolter K, Young C, Redwood S, Thomas M.
    J Thorac Cardiovasc Surg; 2014 Sep; 148(3):917-22; discussion 922-4. PubMed ID: 25037622
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. European experience with the second-generation Edwards SAPIEN XT transcatheter heart valve in patients with severe aortic stenosis: 1-year outcomes from the SOURCE XT Registry.
    Schymik G, Lefèvre T, Bartorelli AL, Rubino P, Treede H, Walther T, Baumgartner H, Windecker S, Wendler O, Urban P, Mandinov L, Thomas M, Vahanian A.
    JACC Cardiovasc Interv; 2015 Apr 27; 8(5):657-69. PubMed ID: 25946437
    [Abstract] [Full Text] [Related]

  • 12. Boston Scientific Lotus valve.
    Meredith IT, Hood KL, Haratani N, Allocco DJ, Dawkins KD.
    EuroIntervention; 2012 Sep 27; 8 Suppl Q():Q70-4. PubMed ID: 22995115
    [Abstract] [Full Text] [Related]

  • 13. Use of transcatheter heart valves for a valve-in-valve implantation in patients with degenerated aortic bioprosthesis: technical considerations and results.
    Bapat V, Attia R, Redwood S, Hancock J, Wilson K, Young C, Thomas M.
    J Thorac Cardiovasc Surg; 2012 Dec 27; 144(6):1372-9; discussion 1379-80. PubMed ID: 23140962
    [Abstract] [Full Text] [Related]

  • 14. Transcatheter aortic valve implantation for high risk patients with severe aortic stenosis using the Edwards Sapien balloon-expandable bioprosthesis: a single centre study with immediate and medium-term outcomes.
    Osten MD, Feindel C, Greutmann M, Chamberlain K, Meineri M, Rubin B, Mezody M, Ivanov J, Butany J, Horlick EM.
    Catheter Cardiovasc Interv; 2010 Mar 01; 75(4):475-85. PubMed ID: 19937781
    [Abstract] [Full Text] [Related]

  • 15. Clinical outcome and paravalvular leakage of the new balloon-expandable Edwards Sapien 3 valve in comparison to its predecessor model (Edwards Sapien XT) in patients undergoing transfemoral aortic valve replacement.
    Bocksch W, Grossmann B, Geisler T, Steeg M, Droppa M, Jorbenadze R, Haap M, Gawaz M, Fateh-Moghadam S.
    Catheter Cardiovasc Interv; 2016 Sep 01; 88(3):466-75. PubMed ID: 27184353
    [Abstract] [Full Text] [Related]

  • 16. Prosthesis-Specific Predictors of Paravalvular Regurgitation after Transcatheter Aortic Valve Replacement: Impact of Calcification and Sizing on Balloon-Expandable versus Self-Expandable Transcatheter Heart Valves.
    Stähli BE, Nguyen-Kim TD, Gebhard C, Erhart L, Frauenfelder T, Tanner FC, Falk V, Landmesser U, Nietlispach F, Lüscher TF, Maier W, Binder RK.
    J Heart Valve Dis; 2015 Jan 01; 24(1):10-21. PubMed ID: 26182615
    [Abstract] [Full Text] [Related]

  • 17. Feasibility and safety of transfemoral implantation of Edwards SAPIEN XT prosthesis without balloon valvuloplasty in severe stenosis of native aortic valve.
    García E, Martín P, Hernández R, Rodríguez V, Fernández A, Gama V, Almería C, Macaya C.
    Catheter Cardiovasc Interv; 2014 Apr 01; 83(5):791-5. PubMed ID: 24285561
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Current balloon-expandable transcatheter heart valve and delivery systems.
    Nietlispach F, Wijesinghe N, Wood D, Carere RG, Webb JG.
    Catheter Cardiovasc Interv; 2010 Feb 01; 75(2):295-300. PubMed ID: 19885917
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.